PACB News and Press, Pacific Biosciences of California Inc. From 04/16/24

PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance PR Newswire Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2...

2024-04-08 09:10:18 ET Auddia AUUD +123% on bagging a U.S. patent for the core AI technology it uses in its flagship faidr app to deliver ad-free AM/FM radio stations to paid subscribers. U Power ( UCAR ) +68% after the electric vehicle ( EV ) company announce...

2024-04-05 14:32:16 ET More on Markets AllianceBernstein spotlights demand shifts in the EV industry We're seeing new money come into Bitcoin – TD Securities Treasury yields continue to climb, see what SA analysts have to say AllianceBernstein warns of...

2024-04-03 08:00:00 ET Summary Welcome to another installment of our monthly Rare Stock Picks series. Today, we're highlighting March 2024 investment picks you may have missed. As you know, some Seeking Alpha analysts are more discerning by nature. Others are finding compelling id...

Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes PR Newswire HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Rep...

2024-03-19 12:42:59 ET Summary PacBio expands product adoption, introducing Revio and Onso, enhancing market and technological reach. Despite 10% growth since 2015, dilution eroded shareholder value; pivot possible with 25% growth through 2029 and improved financing mix. Stand...

PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions PR Newswire HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, ...

2024-02-22 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-02-15 18:39:09 ET Pacific Biosciences of California, Inc. (PACB) Q4 2023 Earnings Conference Call February 15, 2024 05:00 PM ET Company Participants Todd Friedman - Senior Director, Investor Relations Christian Henry - President & Chief Executive Officer ...

2024-02-15 16:10:07 ET More on Pacific Biosciences of California Why Is Pacific Biosciences' Price Action So Bad? (Downgrade) Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth Pacific Biosciences' Revio And Onso Lead Looks Priced In For N...